Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 21-25

  Kirby, Gordon M ^a,e   Batist, Gerald ^a   Fotouhi Ardakani, Nasser ^a   Nakazawa, Hisayoshi ^b   Yamasaki, Hiroshi ^b   Kew, Michael ^c   Cameron, Ross G ^d   Alaoui Jamali, Moulay A ^a,f  

^a MCGILL UNIVERSITY   (Canada)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF GUELPH   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEPATITIS;

ADULT; AFLATOXIN B1; AGED; ALLELES; BASE SEQUENCE; CODON; FEMALE; GENES, P53; HEPATITIS B; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOZAMBIQUE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0029903792     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<21::AID-IJC4>3.0.CO;2-Z     Document Type: Article

References (23)

1. AGUILAR, F., HARRIS, C.C., SUN, T., HOLLSTEIN, M.C. and CERUTTI, P., Geographic variation of p53 mutational profile in nonmalignant human fiver. Science, 264, 1317-1319 (1994).
2. 1 induces the transversion of G → T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. nat. Acad. Sci. (Wash.), 94, 8586-8590 (1993).
3. BEASLEY, R.P., The major etiology of hepatocellular carcinoma. Cancer, 61, 1942-1956 (1988).
4. BRESSAC, B., KEW, M., WANDS, J. and OZTURK, M., Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350, 429-431 (1991).
5. CERUTTI, P.A. and TRUMP, B.F., Inflammation and oxidative stress in carcinogenesis. Cancer Cells, 3, 1-7 (1991).
6. DENG, G., CHEN, L.-C., SCHOTT, D.R., THOR, A., BHARGAVA, V., LJUNG, B.-M., CHEW, K. and SMITH, H.S., Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res., 54, 499-505 (1994).
7. FELLY-BOSCO, E., POURZAND, C., ZIJLSTRA, J., AMSTAD, P. and CERUTTI, P., A genotypic mutation system measuring mutations in restriction recognition sequences. Nucl. Acids Res., 19, 2913-2919 (1991).
8. HARRIS, C.C., Hepatocellular carcinogenesis: recent advances and speculation, Cancer Cells, 2, 146-148 (1990).
9. HAYWARD, N., WALDER, G., GRAHAM, W. and COOKSLEY, E., Hepatocellular carcinoma mutation [Letter]. Nature (Lond.), 352, 764 (1993).
10. HSU I.C., METCALF, R.A., SUN, T., WELSH, J.A., WANG, N.J. and HARRIS, C.C., Mutational hotspot in the p53 gene in human hepatocellular carcinomas [see comments]. Nature (Lond.), 350, 427-428 (1991).
11. HSU, I.C., TOKIWA, T., BENNETT, W., METCALF, R.A., WELSH, J.A., SUN, T. and HARRIS, C.C., p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis, 14, 987-992 (1993).
12. HUSSAIN, S.P., AGUILAR, F., AMSTAD, P. and CERUTTI, P., Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene, 9, 2277-2281 (1994).
13. JAITOVICH GROISMAN, I., YEN, L., FOTOUHI-ARDAKANI, N., ROY, R. and ALAOUI-JAMALI, M.A., Interaction of hepatitis B virus gene products with DNA repair proteins in relation to liver carcinogenesis. Proc. Amer. Assoc. Cancer Res., 37, 803 (1996).
14. 1 metabolism in hepatitis B virus transgenic mice. Mol. Carcinogenesis, 11, 74-80 (1994).
15. MONTESANO, R. and KIRBY, G.M., Chemical carcinogens in human liver cancer, In: C. Brechot (ed.), Primary liver cancer: etiological and progression factors, pp. 79-86, CRC Press, Boca Raton, FL (1994).
16. NAKAZAWA, H., AGUELON, A.M. and YAMASAKI, H., Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Oncogene, 7, 2295-2301 (1992).
17. NAKAZAWA, H., ENGLISH, D., RANDELL, P.L., MAKAZAWA, K., MARTEL, N., ARMSTRONG, B.K. and YAMASAKI, H., UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. not. Acad. Sci. (Wash.), 91, 360-364 (1994).
18. OZTURK, M., BRESSAC, B., PUISIEUX, A., KEW, M., VOLKMANN, M., BOZCALL, S. and MURA, J.S., p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338, 1356-1359 (1991).
19. POURZAND, C. and CERUTTI, P., Genotypic mutation analysis by RFLP/PCR. Mutation Res., 288, 113-122 (1993).
20. ROSS, R.K., YUAN, J.-M., YU, M.C., WOGAN, G.N., QIAN, G.-S., TU, J.-R., GROOPMAN, J.D., GAO, Y.-T. and HENDERSON, B.E., Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946 (1992).
21. SCHECTER, R.L., ALAOUI-JAMALI, M.A., JAITOVITCH GROISMAN, I., YEN, L., CARUSO, J.A. and BATIST, G., Post-transcriptional downregulation of glutathione transferase a in HBV transfected HepG2 cells and in HBV transgenic mice, Proc. Amer. Assoc. Cancer Res., 37, 802 (1996).
22. TERAMOTO, T., SATONAKA, K., KITAZAWA, S., FUJIMORI, T., HAYASHI, K. and MAEDA, S., p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res., 54, 231-235 (1994).
23. WANG, X.W., YEH, H., SCHAEFFER, L., ROY, R., MONCOLLIN, V., EOLY, J.-M., WANG, Z., FREIDBERG, B.C., EANS, M.K., TAFFE, B.G., BOHR, V.A., WEEDA, G., HOEJMAKERS, J.H.J., FORRESTER, K. and HARRIS, C.C., p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature (Genet.), 10, 188-195 (1995).